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Objective: The fate of the dissected distal aorta after surgery for acute type A aortic dissection has not been fully
understood. We assessed the influence of a residual patent false lumen on long-term outcomes.
Methods: Two hundred eighteen patients underwent emergency surgery for DeBakey type I or IIIb retrograde
acute type A aortic dissection (1997–2006). Aortic arch replacement was performed in selected patients whose
entry site was in or extended into the aortic arch. In-hospital mortality was 7.3% (16/218), and 193 survivors
(mean age 62 years) underwent enhanced computed tomography within 1 month after the operation. These
patients were divided into two groups according to the status of the false lumen, whether patent (n ¼ 124) or
thrombosed (n ¼ 69). In each group, segment-specific aortic growth rate, distal reoperation, and late survival
were examined.
Results: Growth rate was determined in 139 (72.0%) patients who underwent serial computed tomography.
Average growth rate in the patent group was greater than that in the thrombosed group (aortic arch [1.1 vs
0.41 mm per year; P ¼ .005], proximal descending aorta [1.9 vs0.71 mm per year; P<.001], and distal de-
scending aorta [1.3 vs0.70 mm per year; P ¼ .002]). However, growth was slow (<1 mmper year) in about
50% of patients in the patent group. There was no significant difference in distal reoperation or late survival
between the two groups.
Conclusions: The patent false lumen influences postoperative aortic enlargement. However, with careful follow-
up, a favorable prognosis is expected even for patients with a residual patent false lumen.Supplemental material is available online.
Acute type A aortic dissection (AAAD) remains one of the
most serious cardiovascular conditions; risk of death is
high. Although operative outcomes for AAAD have im-
proved,1-3 the latest report from the International Registry
of Acute Aortic Dissection Investigators disclosed a still
high hospital mortality rate (23.9% for 682 patients with
AAAD, 1996–2003).4 Prolonged surgery for patients at
risk of death might increase the already high operative risk
through coagulopathy, cerebral ischemia, infection, or mul-
tiorgan failure. We consider the most important goal of ini-
tial surgery for AAAD to be immediate survival; a simple
and less invasive operative procedure is effective for such
patients. Therefore, our surgical strategy for AAAD is based
on the following: First, prompt establishment of cardiopul-
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doi:10.1016/j.jtcvs.2008.05.0521160 The Journal of Thoracic and Cardiovascular Sumonary bypass to prevent malperfusion. Second, preserva-
tion of the aortic valve whenever possible. Third, aortic
arch replacement in patients whose entry site is located in
or extends into the aortic arch. By following this policy,
we have achieved acceptable operative outcomes for
AAAD.5,6
The initial operation does not remove the entire diseased
aorta, and some patients require aortic reoperation for aneu-
rysmal dilatation of the distal aorta. The residual patent false
lumen has recently been reported as a risk factor for second-
ary aortic enlargement.7-9 In addition, several studies have
shown that a more aggressive operative approach for
AAAD, such as systematic extended or total arch replace-
ment, irrespective of the location of the entry site, might
improve long-term outcomes by decreasing the incidence
of residual patent false lumen.2,10-12 However, the effect of
the residual patent false lumen on long-term outcomes is
not fully understood. In the present study, we assessed influ-
ence of the residual patent false lumen on late aortic growth
rate, distal reoperation, and late survival to evaluate the long-
term effectiveness of our surgical strategy for AAAD.
PATIENTS AND METHODS
Patients
Between January 1997 and December 2006, 243 consecutive patients
(127 men and 116 women) with AAAD were treated surgically at Saitama
Medical Center, Jichi Medical University, Saitama, Japan. Aortic dissection
was diagnosed on the basis of enhanced computed tomographic (CT) or
echocardiographic findings, and transesophageal echocardiography was
used for confirmation when possible. Twenty-five patients with dissectionrgery c November 2008
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limited to the ascending aorta and proximal aortic arch were excluded from
the present study. The remaining 218 patients had a false lumen that
extended from the distal aortic arch to the abdominal aorta and received a di-
agnosis of DeBakey type I or IIIb retrograde AAAD. In all patients, emer-
gency surgery was performed within 14 days of acute onset of symptoms,
with 90.8% (198/218) of these operations being performed within 48 hours
of onset. The remaining 9.2% (20/218) of patients underwent surgery more
than 48 hours after onset owing to delay in the diagnosis of AAAD and in
referral to our hospital. In-hospital mortality was 7.3% (16/218). Of the 202
survivors, 193 (95.5%) underwent enhanced CT scanning within 1 month
after the operation. These 193 patients (106 men and 87 women, mean
age, 62.2  11.2 years) constituted the study population, and 9 patients
(4.5%) who did not undergo enhanced CT scanning were excluded. Of
these 9 patients, 7 underwent simple CT scanning only because of renal
insufficiency or an allergy to contrast medium. The remaining 2 patients
refused postoperative CT scanning.
We defined a patent false lumen as a false lumen that was enhanced dur-
ing delayed-phase CT (90–120 seconds after the start of contrast medium
injection). However, in patients who did not undergo delayed-phase CT, pa-
tency of the false lumen was judged on the basis of early-phase data. The
193 patients were divided into two groups according to the status of the re-
sidual false lumen: those with a patent false lumen in the distal aorta (124
patients, mean age 58.7  11.0 years) and those with a totally thrombosed
false lumen in the distal aorta (69 patients, mean age 68.5  8.7 years). If
contrast medium was found anywhere in the distal aorta, the false lumen
was considered patent. Thus, the patent group included patients with a par-
tially thrombosed false lumen in the distal aorta. Patients’ clinical character-
istics and dissection characteristics are shown in Table E1.
Our study followed the guidelines of the Ethical Review Board of Jichi
Medical University. All of the patients had previously granted permission
for use of their medical records for research purposes.
Surgical Procedures
All operations were performed on an emergency basis within 24 hours
after admission. The surgical procedure consisted of median sternotomy
with standard cardiopulmonary bypass via a subclavian artery or femoral ar-
tery cannulation. Once cardiopulmonary bypass was established, systemic
cooling was started immediately. After the onset of ventricular fibrillation,
the aorta was clamped. The proximal stump was trimmed and reinforced
with Teflon felt (DuPont, Parkersburg, WVa) during cooling. The aortic
arch was then explored under circulatory arrest at a rectal temperature of
20C. If the entry site was found in the ascending aorta, ascending aorta re-
placement (including hemiarch replacement) was performed by the open
aorta technique. If the entry site was present or extended into the aortic
arch, partial or total arch replacement was performed with a selective cere-
bral perfusion technique. The placement technique always included the in-
terposition of woven collagen-impregnated or albumin-sealed grafts with
Teflon felt reinforcement of the aortic stumps. Gelatin–resorcin–formalin
adhesive was not used. When the entry site could not be identified or was
identified in the descending aorta by transesophageal echocardiography,
we simply replaced the ascending aorta. Aortic root replacement with a com-
posite prosthesis and reimplantation of the coronary arteries by the modified
Bentall technique was performed in patients with conspicuous dilatation of
the aortic root.The Journal of Thoracic and CaFollow-up
In-hospital data were obtained by retrospective review of hospital re-
cords. Follow-up CT was usually performed at our outpatient clinic or at
one of several neighboring hospitals 6 to 12 months after hospital discharge
and annually thereafter. Other follow-up data including survival time, gen-
eral health condition, aortic reoperation or rupture, and cause of death were
obtained from our outpatient clinic, through written or telephone contact
with patients or relatives, or from local cardiologists. The mean follow-up
period was 4.3  2.8 years (0.6–10.2 years), and follow-up information
was obtained for 100% of the patients.
Aortic Growth Rates
Aortic growth rate was assessed if a patient had undergone at least 2 CT
studies postoperatively with at least 6 months between them. If more than 2
CT studies were performed after hospital discharge, the most recent image
was used to determine the growth rate. Once an aortic segment had been
subjected to reoperative intervention, the patient was excluded from further
assessment of growth rate. In each patient, analyses were performed at 4
different levels of the aorta: the aortic arch, proximal (at the level of the aor-
tic isthmus) and distal (at the level of the supradiaphragm) descending aorta,
and abdominal aorta. The growth rate was calculated as follows13,14: differ-
ence in diameter between the initial (D1) and final (D2) measurements
divided by the time interval (T) between the 2 measurements: that is, growth
rate ¼ (D2D1)/T.
As previously described,9 a number of factors were compared between
patients for whom serial CT scans were available and those for whom
they were not available to determine whether the group who contributed
scans was representative of the entire cohort of patients. The following
factors were examined: age; sex; DeBakey classification; patency of the
residual false lumen; postoperative complications (stroke, need for re-
exploration, renal failure, prolonged ventilator support); presence of aortic
dilatation, chronic obstructive pulmonary disease (COPD), diabetes, hyper-
tension, chronic renal failure, Marfan syndrome, or aortic valve insuffi-
ciency; surgical procedures; proximal or distal reoperation; and late
survival.
Statistical Analysis
All values are expressed as mean  standard deviation. Between-group
differences in clinical and morphologic variables were analyzed by c2 or
Fisher’s exact test or by the unpaired t test or Mann–Whitney U test. Mul-
tivariate logistic regression analysis was performed to identify independent
risk factors for a residual patent false lumen. Time-related events studied in-
cluded death and reoperation in the distal aorta after hospital discharge.
Freedom from these time-related events was estimated by the nonparametric
actuarial Kaplan–Meier method. For the purposes of comparison with other
published data, actuarial survival and freedom from reoperation on the distal
aorta for all patients with AAAD (including 25 patients with DeBakey type
II) are also given. All statistical analyses were performed with SPSS 11.0.1
for Windows software (SPSS, Inc, Chicago, Ill).
RESULTS
Patency of the Residual False Lumen
The incidence of residual patent false lumen on initial
postoperative CT examination was 64.2% (124/193).
Seventy-four (59.7%) of the 124 patients with a residual pat-
ent false lumen had a completely patent false lumen in the
thoracoabdominal aorta. Four (3.2%) patients had a patent
false lumen only in the descending aorta, and 9 (7.3%) pa-
tients had a patent false lumen only in the abdominal aorta.
In the remaining 37 (29.8%) patients, partial thrombosis
was seen in both the descending and abdominal aorta.rdiovascular Surgery c Volume 136, Number 5 1161
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(29.0%, 56/193), 5 patients who had visible entry located
in the proximal descending aorta were treated with total
arch replacement for entry resection. The remaining 51 pa-
tients included 5 whose entry was identified by transesopha-
geal echocardiography and 46 whose entry was not
identified intraoperatively. Patency of the thrombosed false
lumen in patients with type IIIb retrograde AAAD was
39.3% (22/56).
Results of multivariate logistic regression analysis for in-
dependent risk factors for residual patent false lumen are
shown in Table 1. Although male sex, history of smoking,
and preoperative limb ischemia were identified as significant
risk factors by univariate analysis, only age less than 70
years was identified as an independent risk factor for a resid-
ual patent false lumen.
Segment-specific Aortic Growth Rate
Of the 193 patients who underwent the initial enhanced
CT scanning within 1 month after surgery, 54 (27.9%)
were excluded from the growth rate analysis. Two of these
54 patients died within 6months after the operation (1 of car-
diac failure and the other of rupture of the distal aorta). Six of
the 54 patients already showed dilation of the distal aorta at
the time of diagnosis of AAAD and underwent surgery
for the pre-existing aortic aneurysm within 6 months after
the initial operation. Forty-six of the 54 patients were fol-
lowed up by their local cardiologist. There were no signifi-
cant differences in perioperative characteristics between
patients in whom growth rate was assessed and those in
whom it was not. In addition, there was no significant differ-
ence between the two groups in distal aortic reoperation or
late survival (data not shown).
One hundred thirty-nine (72.1%) patients had sufficient
image data for determination of aortic growth rate. These
139 patients included 94 patients with a patent false lumen
and 45 patients with a thrombosed false lumen. Although
the proportion of patients who contributed scans was higher
in the patent group (75.8%, 94/124) than in the thrombosed
group (65.2%, 45/69), the difference was not significant
(P¼ .12). The mean overall CT follow-up period was 3.2
2.0 years (0.6–9.1 years). The mean follow-up period for the
patent group was 3.2  2.1 years, and that for the throm-
bosed group was 2.6  1.9 years (P ¼ .23).
TABLE 1. Results of multivariate logistic regression analysis for
factors predictive of residual patent false lumen after surgery for
acute type A aortic dissection
P value Odds ratio 95% confidence interval
Age<70 y <.001 4.52 2.26–9.01
Limb ischemia .148 2.37 0.74–7.60
Male sex .378 1.42 0.65–3.12
History of smoking .555 1.26 0.58–2.751162 The Journal of Thoracic and Cardiovascular SuThe mean initial diameter and growth rate for each aortic
segment are shown in Table 2. At the proximal and distal de-
scending aorta, the mean initial aortic diameter was slightly
but significantly greater in the patent group than in the
thrombosed group. In both groups, the largest segment of
the distal aorta on the initial CT scan was the aortic arch;
this was followed by the proximal descending aorta, distal
descending aorta, and abdominal aorta. At all segments of
the distal aorta, the mean growth rate was greater in the pat-
ent group than in the thrombosed group, and between-group
differences at the aortic arch, proximal descending aorta, and
distal descending aorta were significant. The mean growth
rates in the patent group ranged from 1.1 to 1.9 mm per
year. However, about 50% of patients with a residual patent
false lumen showed a growth rate of less than 1 mm per year
at all aortic segments. In contrast, the mean growth rates in
the thoracic aorta of the thrombosed group were less than
0 mm per year, and only 15% to 32% of patients with
a thrombosed false lumen showed a growth rate more than
1 mm per year at all aortic segments. The distal aorta of
the thrombosed group frequently became a single-barrel
chamber because the thrombosed false lumen disappeared
during the follow-up period. This later disappearance of
the thrombosis led to the negative aortic growth found in
the thrombosed group.
Segment-specific aortic growth data are shown for indi-
vidual patients in Figure 1. Most patients in the thrombosed
group showed no or only slight aortic enlargement. In con-
trast, some patients in the patent group showed rapid aortic
enlargement.
TABLE 2. Mean initial diameters and aortic growth rate in the two
study groups
Patent group
(n ¼ 94)
Thrombosed
group
(n ¼ 45) P value
Initial diameter (mm)
Aortic arch 39.4  5.4 38.6  5.4 NS
Proximal descending aorta 34.5  5.0 32.5  5.1 .02
Distal descending aorta 31.7  5.7 29.7  3.6 .03
Abdominal aorta 27.3  5.2 27.3  8.2 NS
Growth rate (mm/y)
Aortic arch 1.1  4.0 0.41  2.4 .005
Proximal descending aorta 1.9  3.8 0.71  2.8 <.001
Distal descending aorta 1.3  3.7 0.70  2.9 .002
Abdominal aorta 1.6  4.6 0.52  4.0 NS
Growth rate>1.0 mm/year
Aortic arch (%) 47.9 (45/94) 20.0 (9/45) .002
Proximal descending
aorta (%)
50.0 (47/94) 17.8 (8/45) <.001
Distal descending
aorta (%)
52.1 (49/94) 20.0 (9/45) <.001
Abdominal aorta (%) 47.9 (45/94) 33.3 (15/45) NSrgery c November 2008
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eration occurred or follow-up (death or final follow-up) ended. Patent group, n ¼ 94; thrombosed group, n ¼ 45. FL, False lumen.Late Reoperation on the Distal Aorta
Our criterion for reoperation on the distal aorta was an
aortic diameter of more than 60 mm. During the follow-up
period, 8 (4.1%) patients underwent 8 late reoperations on
the distal aorta (3 in the aortic arch, 5 in the descending
aorta). Nine operations for pre-existing aortic aneurysm in
the distal aorta (1 in the aortic arch, 1 in the descending aorta,
7 in the abdominal aorta) were excluded from assessment of
late reoperation on the distal aorta, and 6 of these 9 opera-
tions were performed within 6 months after the initial oper-
ation for AAAD. Seven of the 8 patients who underwent late
reoperation on the distal aorta had a patent false lumen, and
only 1 patient with a thrombosed false lumen required late
reoperation on the distal aorta. Seven of the 8 reoperations
were performed electively. There was no perioperative death
associated with these reoperations.
Freedom from distal aortic reoperation for all hospital sur-
vivors including the patients with DeBakey type II aorticThe Journal of Thoracic and Cadissection (n ¼ 226) was 99.0%  0.7% at 1 year,
97.4%  1.3% at 5 years, and 89.5%  4.2% at 10 years
(Figure E1, A). Freedom from distal aortic reoperation in the
patent group (n ¼ 124) was 98.3%  1.2%, 95.6% 
2.2%, 88.0%  4.7% at 1, 5, and 10 years, respectively,
and that for the thrombosed group (n ¼ 69) was 100% 
0%, 100% 0%, and 91.7% 8.0% at 1, 5, and 10 years,
respectively. Although there was a tendency for the throm-
bosed group to have the better distal reoperation-free rate,
the difference was not significant (P ¼ .16) (Figure 2, A).
During the same period, there were 5 proximal aortic re-
operations owing to development of aneurysmal aortic sinus
associated with aortic regurgitation. Of the total of 243 pa-
tients who underwent surgery for AAAD, only 6 hadMarfan
syndrome. In-hospital mortality for these patients was
16.7% (1/6). One of the 5 discharged patients underwent
proximal aortic reoperation. However, no distal aortic reop-
eration was performed in patients with Marfan syndrome.rdiovascular Surgery c Volume 136, Number 5 1163
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patients with and without a patent false lumen.Long-term Survival
Twenty-four patients died during the follow-up period.
The leading cause of late death was malignancy (33.3%,
8/24) (Table E2). In 2 of the 8 patients who died of malig-
nancy, malignancy was diagnosed during hospitalization
for AAAD. The second leading cause of late death was car-
diac failure (29.2%, 7/24), including myocardial infarction
(n ¼ 3), congestive heart failure (n ¼ 3), and sudden death
without distal aortic aneurysm (n ¼ 1). Four (16.7%) pa-
tients died of ruptured aortic aneurysm in the distal aorta;
all 4 belonged to the patent group.
Actuarial survival, with in-hospital deaths counted for all
patients including those with DeBakey type II aortic dissec-
tion (n ¼ 243), was 89.5%  2.0% at 1 year, 79.5% 
3.0% at 5 years, and 71.3%  4.3% at 10 years
(Figure E1, B). Actuarial survival for the patent group
(n¼ 124) was 96.7% 1.6%, 87.9% 3.4%, and 79.0%
 5.3% at 1, 5, and 10 years, respectively, and that for the
thrombosed group (n ¼ 69) was 96.8%  2.2%, 87.9%
 4.8%, and 75.0%  8.4% at 1, 5, and 10 years, respec-
tively. Long-term survival between groups was similar and
without significant difference (Figure 2, B).
DISCUSSION
With advances in surgical techniques and perioperative
care, surgical outcomes of AAAD have recently improved.
In-hospital mortality in this series of patients was 7.3%
(16/218), which was comparable with previous reports. We
believe this was associated to some extent with our surgical
approach. First, proximal stump formation was performed
during the cooling period with an aortic crossclamp in place.
An aortic crossclamp may cause further damage to the dis-
sected aortic wall and cerebral malperfusion by applying
pressure to the false lumen, but this approach can shorten car-
diopulmonary bypass time. Second, we have tried to preserve
the aortic valve whenever possible. In the present series, aor-
tic root replacement (modified Bentall operation) was per-
formed in only 6 (3.1%) of 193 patients, mainly because of
the quite small number of patients with Marfan syndrome
(2.6%, 5/193).1164 The Journal of Thoracic and Cardiovascular SuA residual patent false lumen is considered to be the cause
of unresected or secondary entry in the distal aorta. Although
complete resection of all entry sites is required for thrombo-
sis of the residual false lumen, initial surgery for AAAD fails
to achieve this objective, particularly in patients with pri-
mary or secondary entry located in the descending thoracic
or abdominal aorta. To decrease the incidence of residual
patent false lumen, some authors recommend systematic ex-
tended or total arch replacement for the initial surgical man-
agement of AAAD, irrespective of the site of entry.2,10-12
The main benefit of this approach is complete resection of
a small, invisible entry site located in the aortic arch.12
The incidence of residual patent false lumen was 64.2%
(124/193) in our series of patients. This was in accordance
with results of previous studies (43%–78%) in which aortic
arch replacement was performed in selected patients8,9,15-17;
however, it was higher than the 27% to 46% incidence of
residual patent false lumen reported by other groups that
used aortic arch grafting in all patients with AAAD extend-
ing to the descending aorta.2,11,12 It is possible that the low
percentage of aortic arch replacements in the present series
(14.0%, 27/193) led to the relatively high rate of residual
false lumen patency. Other reported risk factors for residual
patent false lumen after surgery for AAAD include Marfan
syndrome, preoperative extension of the false lumen, male
sex, and increased aortic diameter.2,7 In the present study,
age less than 70 years was identified as an independent
risk factor for residual patent false lumen after surgery for
AAAD. This finding was similar to that of Tsai and associ-
ates.18 It has been reported that younger age is associated
with late aortic enlargement in patients with type B aortic
dissection.14,19 The elasticity and distensibility of the aorta
decline with age. Sueyoshi and colleagues.14 hypothesized
that loss of elasticity might limit enlargement of the aorta
in patients with aortic dissection. However, the reason
why age less than 70 years was associated with residual pat-
ent false lumen in our study is unknown, and further inves-
tigation is needed.
The major finding of the present study was that the resid-
ual patent false lumen strongly influences aortic growth ratergery c November 2008
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of previous studies showing that the residual patent false lu-
men is a risk factor for faster aortic growth in patients with
aortic dissection.7-9,14,17,19,20 A new finding is that about
50% of the patients with residual patent false lumen showed
an aortic growth rate of less than 1 mm per year at all aortic
segments, indicating that the residual patent false lumen is
not necessarily associated with secondary enlargement of
the distal aorta. Although the distal aorta with a residual pat-
ent false lumen tends to enlarge, the aortic growth rate is
generally slow, and it takes a relatively long time for a large
aneurysm requiring surgical intervention to develop. In the
present study, freedom from distal aortic reoperation and
long-term survival were similar in patients with and without
residual patent false lumen; the findings of Sabik and co-
workers21 were similar.
We observed a relatively low incidence of distal reopera-
tion (89.5% freedom from reoperation at 10 years), similar
to incidences reported by other groups who performed aortic
arch replacement in selected patients (77%–91% freedom
from distal reoperation at 10 years).21,22 Although reopera-
tion-free rates reported by groups adopting routine aortic
arch replacement for AAAD were also satisfactory (77%–
93% freedom from reoperation at 10 years),10,12 reopera-
tion-free rates were similar between groups. We agree that
extended aortic arch replacement can decrease the incidence
of residual patent false lumen. However, it remains unclear
whether this approach can decrease the need for reoperation
in the distal aorta and improve late survival. We believe that
surgical technique alone is not the main determinant of the
natural history of the distal aorta after surgery for AAAD.
Crawford and associates23 recommended replacing the aor-
tic arch only when it is aneurysmal and there is excessive
enlargement and impending or actual rupture of the false
lumen, but not treating a false lumen in the aortic arch.
Recently, some groups that routinely use extended aortic
arch replacement have reported excellent operative out-
comes, with mortality ranging from 4.7% to 10%.2,11,12
However, such an aggressive approach might increase the
already high operative risk. In the present study, in-hospital
mortality for patients who underwent total or partial arch re-
placement was higher than that for patients who underwent
ascending aorta or hemiarch replacement (10% [3/30] vs
6.9% [13/188]; P¼ .82). The difference was not significant,
but we consider that this risk largely outweighs the rela-
tively low incidence of reoperation in the distal aorta and
its associated operative risk. As noted earlier, elderly pa-
tients tend to have a thrombosed false lumen after initial sur-
gery for AAAD. Therefore, especially when a patient is
elderly or has at least one of various preoperative complica-
tions, our relatively conservative operative approach seems
to be reasonable.
Another finding of the present study was that some pa-
tients with a patent false lumen can show unusually rapidThe Journal of Thoracic and Caortic enlargement. Enlarged aorta is reported to be related
to a faster growth rate in patients with aortic dissec-
tion.7,9,20,24 In the present study, significant differences
were found in the initial aortic diameter at the proximal
and distal descending thoracic aorta. This suggests that not
only patency of the residual false lumen but also initial aortic
diameter has some influence on late aortic growth. The other
reported risk factors for aortic enlargement or distal reoper-
ation after surgery for AAAD include nonresection of the
entry site, distal extension of a dissection, and Marfan
syndrome22,24-26 We think that when young patients who
are in stable condition show such risk factors, extended
arch replacement is a preferable operative approach and
can decrease the need for late reoperation in the distal aorta.
Zierer and colleagues24 recently reported that uncontrolled
hypertension is a risk factor for late aortic enlargement.
Careful antihypertensive therapy seems to be important for
prevention of later aortic enlargement.
Reported 10-year survivals with in-hospital deaths
counted ranged from 37% to 71%.15,21,22,25,26 Although pa-
tient characteristics are not comparable, the 71% survival at
10 years in our series was acceptable. DeBakey and col-
leagues27 reported that rupture of the distal aorta was the
most common cause of death in patients with AAAD, ac-
counting for 29.3% of 205 late deaths. In this series, the
most common cause of late death was malignancy. How-
ever, despite close surveillance, 4 patients died of rupture
of the distal aorta, and all 4 had a residual patent false lumen.
Although careful follow-up is mandatory to prevent rupture
of the distal aorta, the decision to perform repeat surgical in-
tervention in a stable, asymptomatic patient is another im-
portant issue. For timely reoperation, we must take into
account not only comorbidities and the aortic diameter but
also the status of the residual false lumen. As mentioned ear-
lier, results of reoperation in the distal aorta were satisfactory
(no perioperative deaths among 8 patients who underwent
reoperation). Therefore, we consider distal reoperation to
be necessary when the aortic diameter reaches 55 mm in
otherwise healthy young patients with a patent false lumen.
Favorable results of endovascular treatment for acute or
chronic aortic dissection were recently reported, with high
rates of success with false lumen thrombosis.28 Endovascu-
lar treatment can be an effective approach even for elderly or
severely compromised patients.
Study Limitations
The present study had several limitations. For assessment
of aortic growth rate, follow-up CT examinations were per-
formed in only 139 (72%) of the 193 patients who under-
went initial postoperative enhanced CT scan and were
discharged from the hospital. An important question was
whether the patients who contributed serial CT scans were
representative of the entire cohort of patients who survived
the initial operation for AAAD. However, there was noardiovascular Surgery c Volume 136, Number 5 1165
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characteristics or long-term outcomes.
Another limitation is related to the CT scanning. Since
2002, we have routinely performed an initial postoperative
enhanced CT examination, both early and delayed phase.
However, before 2002, some CT examinations were per-
formed only in the early phase. Therefore, we might have
underestimated the actual incidence of residual patent false
lumen owing to misclassification of the false lumen. More-
over, enhanced CT scanning was not routinely performed
in all patients who were included in the growth rate assess-
ment. This is because follow-up CT examinations after dis-
charge were not standardized between our hospital and the
neighboring hospitals. Therefore, we were unable to evalu-
ate long-term changes in the diameter of the true and false
lumina.
The third limitation was the relatively short follow-up
period. The mean follow-up period was 4.3 years, which
was shorter than the 10- to 20-year follow-up periods of
previous studies on long-term survival after surgery for
AAAD.15,21,22,25-27With a longer follow-up period, a signif-
icant difference in the distal reoperation-free rate may be-
come evident between patients with and without a residual
patent false lumen, and patients with patent false lumina
may be shown to have poorer late outcomes. Further studies
involving larger numbers of patients with a longer follow-up
period are required.
CONCLUSIONS
The present study revealed that the residual patent false
lumen influences enlargement of the distal aorta after sur-
gery for AAAD. However, the residual patent false lumen
was not necessarily associated with faster aortic growth. De-
spite the fact that our conservative surgical approach led to
a relatively high incidence of residual patent false lumen,
the long-term outcomes were acceptable and did not differ
according to the status of the residual false lumen. We be-
lieve that careful follow-up may provide a favorable postop-
erative prognosis even in patients with a residual patent false
lumen after surgery for AAAD. The residual false lumen in
elderly patients tended to be thrombosed postoperatively;
thus, our strategy for AAAD seems to be effective, espe-
cially for elderly patients.
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DFIGURE E1. Kapla n–Meier curves. A, Freedom from distal aortic reoperation in all survivors including patients with DeBakey type II aortic dissection
(n ¼ 226). B, Actuarial survival in all patients including those with DeBakey type II aortic dissection (including in-hospital deaths, n ¼ 243).The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1166.e1
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DTABLE E1. Patient characteristics per study group
Patent group (n ¼ 124) Thrombosed group (n ¼ 69) P value
Clinical background
Age 70 years or older (%) 20 (16.1) 35 (50.8) <.001
Male sex (%) 77 (62.1) 29 (42.0) .007
Marfan syndrome (%) 4 (3.2) 1 (1.4) NS
Hypertension (%) 85 (68.5) 46 (66.7) NS
Diabetes (%) 9 (7.3) 4 (5.8) NS
History of smoking (%) 70 (56.5) 27 (39.1) .021
CAD (%) 5 (4.0) 6 (8.7) NS
Preoperative CVD (%) 10 (8.1) 7 (10.1) NS
COPD (%) 3 (2.4) 2 (2.9) NS
Chronic hemodialysis (%) 1 (0.8) 0 (0) NS
Redo (%) 4 (3.2) 0 (0) NS
Dissection characteristics
Severe aortic regurgitation (%) 13 (10.5) 3 (4.3) NS
TIA or neurological deficits (%) 16 (12.9) 10 (14.5) NS
Myocardial ischemia (%) 7 (5.6) 5 (7.2) NS
Visceral ischemia (%) 5 (4.0) 4 (5.8) NS
Limb ischemia (%) 22 (17.7) 4 (5.8) .035
Aortic diameter>60 mm (%) 13 (10.3) 14 (20.3) NS
Location of the intimal tear (%)
Ascending aorta 58 (46.8) 26 (37.7) NS
Ascending aorta to aortic arch 19 (15.3) 14 (20.3) NS
Aortic arch 16 (12.9) 10 (14.5) NS
Unidentified (or descending aorta) 31 (25.0) 20 (29.0) NS
DeBakey classification
Type I 90 (72.6) 47 (68.1) NS
Type III b retrograde 34 (27.4) 22 (31.9) NS
Distal replacement (%)
Ascending aorta/hemiarch 107 (86.3) 59 (85.5) NS
Ascendingþaortic arch 17 (13.7) 10 (14.5) NS
Proximal reconstruction (%)
Valve resuspension 114 (91.9) 69 (100) NS
Modified Bentall 6 (4.8) 0 (0) NS
Isolated aortic valve replacement 4 (3.2) 0 (0) NS
CABG (%) 11 (8.9) 6 (8.7) NS
Entry resection (%) 92 (74.2) 49 (71.0) NS
CAD, coronary artery disease;CVD, cerebrovascular disease;COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack;CABG, coronary artery bypass grafting;
NS, not significant.1166.e2 The Journal of Thoracic and Cardiovascular Surgery c November 2008
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DTABLE E2. Causes of late mortality in the two study groups
Total patients Patent group Thrombosed group
Malignancy 8 (33%) 4 (25%) 4 (50%)
Cardiac failure 7 (29%) 4 (25%) 3 (38%)
Ruptured aneurysm 4 (17%) 4 (25%) 0 (0%)
Stroke 2 (8%) 1 (6%) 1 (13%)
Renal failure 1 (4%) 1 (6%) 0 (0%)
Respiratory failure 1 (4%) 1 (6%) 0 (0%)
Hemorrhage 1 (4%) 1 (6%) 0 (0%)
Total 24 (100%) 16 (100%) 8 (100%)
Number and percentage of patients are shown. Differences were not significant.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 5 1166.e3
